Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NPIPL1 Inhibitors

NPIPL1 inhibitors are a class of compounds designed to interact specifically with the NPIPL1 (Nuclear Pore Interacting Protein-Like 1) protein. The NPIPL1 protein is related to the nuclear pore complex, which plays a crucial role in cellular functions by mediating the transport of molecules between the nucleus and the cytoplasm. These inhibitors typically act by binding to the NPIPL1 protein and modulating its function, thereby affecting its interactions and possibly altering its role within the cellular environment. The structure of these inhibitors is often complex and may include multiple functional groups capable of establishing strong interactions, such as hydrogen bonds or hydrophobic contacts, with the NPIPL1 protein. This specificity is critical for their ability to selectively target NPIPL1 without significantly impacting other proteins or pathways within the cell.

The development of NPIPL1 inhibitors has necessitated a detailed understanding of the protein's structure, binding sites, and interactions with other cellular components. The inhibitors are often designed to fit into specific pockets or domains on NPIPL1, thereby modulating its activity or preventing it from engaging with its normal interaction partners. This specificity is typically achieved through various chemical modifications of the inhibitor's molecular structure, optimizing its affinity and selectivity for NPIPL1. Research into these inhibitors involves extensive screening for compounds that can effectively and specifically modulate NPIPL1 function, followed by optimization of their binding properties and stability. Due to the importance of the nuclear pore complex in regulating cellular transport and maintaining cellular homeostasis, NPIPL1 inhibitors represent an important tool for studying these processes in greater detail and exploring how alterations in NPIPL1 function can affect nuclear-cytoplasmic transport and cellular physiology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits protein synthesis by interfering with the translocation step in protein synthesis, potentially reducing the overall levels of NPIPL1.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Inhibits proteasomes, which could prevent the degradation of a ubiquitin-tagged regulatory protein that controls NPIPL1 levels, indirectly increasing NPIPL1 accumulation.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Inhibits protein kinases, which could alter phosphorylation states of proteins in the pathway involving NPIPL1, affecting its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, potentially altering the AKT signaling pathway, which may indirectly influence NPIPL1's activity or stability.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, which may alter the translation of proteins involved in the same pathway as NPIPL1, affecting its function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which could affect MAPK/ERK signaling, potentially altering the activity of proteins that interact with or regulate NPIPL1.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, potentially affecting stress response pathways that could regulate NPIPL1 activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibits MEK1/2, which may affect the MAPK/ERK pathway, potentially altering the regulation of NPIPL1.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Inhibits Hsp90, which could affect the folding and stability of proteins that are involved in the same pathway as NPIPL1.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which could modulate the activity of transcription factors that regulate the expression of NPIPL1.